Research In Cancer and Tumor

International Journal of Cancer and Tumor is a peer-reviewed international journal which provides a forum for prompt communication of original and innovative research findings that have relevance to understanding the etiology of cancer and to improving the treatment and survival of patients.

Bishnuhari Paudyal

Editorial Board Member of Research In Cancer and Tumor

Assistant Professor, Thomas Jefferson University, USA

Research Areas

Nuclear Medicine, Oncology, Molecular Imaging Using FDG-PET, Multimodality

Education

2008Ph.DDepartment of Diagnostic Radiology and Nuclear Medicine, Gunma University, Graduate School of Medicine, Maebashi City, Japan
2002M.D.Medicine, Virgen Milagrosa University, San Carlos City, Philippines
2000MasterPublic Health, Graduated Cum Laude, Lyceum Northwestern University, Dagupan City, Philippines
1997B.S. BioBiology, University of Baguio, Baguio City, Philippines

Experience

2010-presentResearch Associate: Department of Radiology, Thomas Jefferson University, Philadelphia, USA
2008-2010JSPS Postdoctoral Fellow: Gunma University, Maebashi City, Gunma, Japan
2008Researcher: COE Program of Gunma University, Maebashi City, Japan
2008COE Research Assistant: COE Program of Gunma University, Japan
2003Medical Officer: Bir hospital, Kathmandu, Nepal
1995Radiographic Technician: TU Teaching Hospital, Kathmandu, Nepal
1987-1995Community Health Worker: Different District, Under Ministry of Health, Nepal

Academic Achievement

Nepal Bidyabhushan 'K' ('A' Class Gold Medal of Nepal)
Government of Nepal, National academic excellence award conferred by Honorable Dr. Rambaran Yadav President of Nepal, 2010
Mahendra Bidyabhushan Medal ('B' Class Gold Medal of Nepal): Government of Nepal, National academic excellence award conferred by His Majesty Gyanendra the King of Nepal, 2003
Asian and Oceania Distinguished Young Investigator's: Japanese Society of Nuclear Medicine, 2005
Introduction to Research for International Young Academics (IRIYA): Radiological Society of North America (RSNA), USA, 2009
Postdoctoral Fellowship award: Japanese Society of the Promotion Science (JSPS) 2008
Monbukagakusho for Graduate study: Ministry of Education, Science and Technology, Japan, 2003
CUM LAUDE: Lyceum Northwestern University, Dagupan City, Philippines, 2000
Token of Appreciation for delivering the excellent Invited lecture: JSPS, 2009
Token of Appreciation for delivering the excellent lecture: IAEA RCA, 2006
Travel Award: Singapore General Hospital for Nuclear Medicine Update, 2009
Travel Award: International Conference on Radiopharmaceutical Therapy (ICRT-2009) Cartagena, Colombia, 2009
Excellent Researcher of the year: Lyceum Northwestern University, Philippines, 2000
Scholarship for College of Medicine (MD): Verein Ausbildungshilfe, Germany, 1997-2001
Government scholarship for undergraduate studies: Govt. of Nepal, 1992-1995

Membership

Member of Radiological Society of North America (RSNA), USA
Member of Society of Nuclear Medicine (SNM), USA
Member of Japanese Society of Nuclear Medicine (JSNM), Japan
Member of Japanese Society of Molecular Imaging (JSMI), Japan
Life member of Nepal Medical Association (NMA), Nepal
Board of Directors: The Nepal Foundation, USA

Publications: Conferences/Workshops/Symposiums/Journals/Books

[1]  Sadri K, Ren Q, Zhang K, Paudyal B, Kumar D, Rodeck U, Thakur M. PET Imaging of EGFR expression in nude mice bearing MDA-MB-468, human breast adenocarcinoma. Nucl Med Commun 32:563-569, 2011.
[2]  Thakur ML, Zhang K, Paudyal B, Devakumar D, Covarrubias MY, Cheng C, Gray BD, Wickstrom E, Pak KY. Targeting Apoptosis for Optical Imaging of Infection. Mol Imaging Biol. 2011 May 3.
[3]  Paudyal B, Paudyal P, Oriuchi N, Hanaoka H, Tominaga H, Endo K. PET imaging and biodistribution of VEGF with 64Cu-labeled bevacizumab in colorectal cancer xenografts. Cancer Science. 102: 117-21, 2011
[4]  Akiyasu T, Paudyal B, Paudyal P, Yoshitaka I, Keiju H, Yoshihisa N., and Minoru K. Effectiveness of oral iron to manage anemia in long-term hemodialysis patients with the use of ultrapure dialysate, Exp Thera Med.1; 5: 777-781, 2010, DOI: 10.3892/etm.2010.122. July, 2010
[5]  Paudyal B, Paudyal P, Tsushima Y, Oriuchi N, Amanuma M, Miyazaki M, aketomi-Takahashi A, Nakazato Y, Endo K. The role of the ADC value in the characterisation of renal carcinoma by diffusion-weighted MRI. Br J Radiol. 83; 988: 336-343, Apr, 2010
[6]  Akiyasu T, Paudyal B, Paudyal P, Kumiko M, Kazue U, Takuji N, Takashi K, Yoshihisa N, Minoru K. A case report of acute renal failure associated with bee pollen contained in nutritional supplements. Ther Apher Dial.14; 1: 93-97, Feb, 2010
[7]  Paudyal P, Paudyal B, Hanaoka H, Oriuchi N, Iida Y, Yoshioka H, Tominaga H, Watanabe S, Watanabe S, Ishioka NS, Endo K. Imaging and biodistribution of Her2/neu expression in non-small cell lung cancer xenografts with (64)Cu-labeled trastuzumab PET. Cancer Sci. 101; 4: 1045-1050, Mar, 2010
[8]  Ishikita T, Oriuchi N, Higuchi T, Miyashita G, Arisaka Y, Paudyal B, Paudyal P, Hanaoka H, Miyakubo M, Nakasone Y, Negishi A, Yokoo S, Endo K.　Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancy.　Ann Nucl Med. 24; 1: 77-82, Jan, 2010
[9]  Paudyal P, Paudyal B, Iida Y, Oriuchi N, Hanaoka H, Ishikita T, Yoshioka H, Higuchi T, and Endo K. Dual functional molecular imaging probe targeting CD20 with PET and optical imaging. Oncology Rep. 22; 1: 115-119, Jul, 2009
[10]  Hanaoka H, Tominaga H, Yamada K, Paudyal P, Iida Y, Watanabe S, Paudyal B, Higuchi T, Oriuchi N, Endo K. Evaluation of (64) Cu-labeled DOTA-D:-Phe (1)-Tyr (3)-octreotide (64) Cu-DOTA-TOC) for imaging somatostatin receptor-expressing tumors. Ann Nucl Med. 23; 6: 559-567, Jun, 2009
[11]  Miyazaki M, Tsushima Y, Miyazaki A, Paudyal B, Amanuma M, Endo K.Quantification of hepatic arterial and portal perfusion with dynamic computed tomography: comparison of maximum-slope and dual-input one-compartment model methods. Jpn J Radio. 27; 3: 143-150, April, 2009
[12]  Hanaoka H, Katagiri T, Fukukawa C, Yoshioka H, Yamamoto S, Iida Y, Higuchi T, Oriuchi N, Paudyal B, Paudyal P, Nakamura Y, Endo K.Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: therapeutic efficacy largely depends on radiosensitivity. Ann Nucl Med. 23; 5: 479-485, May, 2009
[13]  Paudyal B, Paudyal P, Oriuchi N, Tsushima Y, Nakajima T, Endo K. Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma. Int J Oncol. 33; 5: 1047-1054, Nov, 2008
[14]  Paudyal B, Oriuchi N, Paudyal P, Higuchi T, Nakajima T and Endo K. Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography. Cancer Science. 99: 2; 260-266, Feb, 2008
[15]  Paudyal B, Oriuchi N, Paudyal P, Tsushima Y, Higuchi T, Miyakubo M, Ishikita T, Nakajima T and Endo K. Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma. Ann Nucl Med. 22: 1; 83-86, Jan, 2008
[16]  Paudyal B, Oriuchi N, Paudyal P, Tsushima Y, Iida Y, Higuchi T, Hanaoka H, Miyakubo M, Takano A, Ishikita T and Endo K. Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy. Oncol Rep. 18: 6; 1469-1473, Dec, 2007
[17]  Miyakubo M, Oriuchi N, Tsushima Y, Higuchi T, Koyama K, Arai K, Paudyal B, Iida Y, Hanaoka H, Ishikita T, Nakasone Y, Negishi A, Mogi K and Endo K. Diagnosis of maxillofacial tumor with L-3-[18f]-fluoro-alpha-methyltyrosine (FMT) PET: a comparative study with FDG-PET. Ann Nucl Med. 21: 2; 129-135, Feb, 2007
[18]  Paudyal B. A case study on the effects of Iodized water consumption among high school students. Journal of Lyceum Northwestern. 4: 2, 49-54, April, 2001
[19]  Paudyal B, Paudyal P, Hanaoka H, Yasuhiko I, Yoshioka H, Tominaga H, Oriuchi N, and Endo K. Targeted imaging with 64Cu trastuzumab PET in non small cell lung cancer. World Journal of Nuclear Medicine, 8; 4: 257, Oct, 2009
[20]  Paudyal B, Paudyal P, Hanaoka H, Tominaga H, Yoshioka H, Yamamoto S, Oriuchi N, and Endo K. Radioimmuno PET imaging of vascular endothelial growth factor in colon cancer. Eur J Nucl Med Mol Imaging, 36: S2; 475, Oct, 2009
[21]  Paudyal B, Paudyal P, Hanaoka H, Tominaga H, Yoshioka H, Oriuchi N,and Endo K. 64Cu labeled PET for the vascular endothelial growth factor in colon cancer. Japanese Journal of Nuclear Medicine, 46: 3; 265, Sep, 2009
[22]  Paudyal P, Paudyal B, Oriuchi N, Iida Y, Hanaoka H, Tominaga H and Endo K. Near Infrared fluorescence imaging of angiogenesis. Japanese Journal of Nuclear Medicine, 46: 3; 265, Sep, 2009
[23]  Paudyal B, Paudyal P, Iida Y, Hanaoka H, Yoshioka H, Tominaga H, Oriuchi N, Higuchi T and Endo K. Potential utility of 64Cu labeled monoclonal antibody for imaging with PET. Eur J Nucl Med Mol Imaging, 35: S2; 329, Oct, 2008
[24]  Paudyal P, Paudyal B, Iida Y, Hanaoka H, Oriuchi N and Endo K. Multimodality Molecular Imaging of Lymphoma with Combined PET and Optical Modality. Japanese Journal of Nuclear Medicine, 45: 3; 195, Sep, 2008
[25]  Paudyal B, Oriuchi N, Paudyal P, Tsushima Y, Higuchi T, Miyakubo M, Nakajima T and Endo K. Glucose transporters and HK II expression in hepatocellular carcinoma compared with FDG-PET. J Nucl Med, 48: S2; 140, May, 2007
[26]  Paudyal B, Oriuchi N, Subedi P, Iida Y, Higuchi T, Hanaoka H, Miyakubo M, Ishikita T, Koyama J, Nakajima T and Endo K. FDG-PET and immunohistochemical staining to differentiate Hepatocellular Carcinoma and Cholangiocellular carcinoma. World Journal of Nuclear Medicine, 5: S1; 192-193, Oct, 2006
[27]  Paudyal B, Oriuchi N, Subedi P, Iida Y, Higuchi T, Hanaoka H, Miyakubo M, Ishikita T, Nakajima T and Endo K. Expression of Glucose Transporter-1 in Cholangiocarcinoma Compared with 18F-FDG Uptake. Japanese Journal of Nuclear Medicine, 43: 3; 226, Oct, 2006
[28]  Paudyal B, Oriuchi N, Subedi P, Higuchi T, Miyakubo M, Iida Y, Nakajima T and Endo K. Glucose transporters expression in hepatocellular carcinoma compared with FDG-PET. Eur J Nucl Med Mol Imaging, 33: S2; 257-258, Sep, 2006
[29]  Paudyal B, Oriuchi N, Miyakubo M, Iida Y, Nakajima T and Endo K. Expression of Glucose transporter in hepatocellular carcinoma compared with FDG-PET. Nippon Acta Radiologica, 25: S1; 220; Feb, 2006
[30]  Paudyal B, Oriuchi N, Subedi P, Higuchi T, Miyakubo M and Endo K. Correlation between FDG-PET and Alpha Fetoprotein in the Evaluation of Recurrent Hepatocellular Carcinoma Treated with Radiofrequency Ablation. Japanese Journal of Nuclear Medicine, 42: 3; 314, Sept, 2005
[31]  Paudyal B, Oriuchi N, Subedi P, Higuchi T, Tian M, Miyakubo M, Iida Y and Endo K. Use of FDG-PET in the evaluation of recurrent hepatocellular carcinoma treated with radiofrequency ablation. Internal Medicine Journal, 35: S1; 13, Mar, 2005